← Back to patent-cliff list
CAS 262857-00-1
benzyl (2-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)-2-hydroxyethyl)(6-(4-phenylbutoxy)hexyl)carbamate
Codes：SALM-009
Application context (from source-drug indications)
哮喘布地奈德/昔萘酸沙美特罗
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 布地奈德/昔萘酸沙美特罗Budesonide/Salmeterol xinafoate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1,6-dibromohexane→4-phenylbutan-1-ol→(4-((6-bromohexyl)oxy)butyl)benzene→2,2-dimethoxyethanamine→N-(2,2-dimethoxyethyl)-6-(4-phenylbutoxy)hexan-1-amine→benzyl (2,2-dimethoxyethyl)(6-(4-phenylbutoxy)hexyl)carbamate→benzyl (2-oxoethyl)(6-(4-phenylbutoxy)hexyl)carbamate→6-bromo-2,2-dimethyl-4H-benzo[d][1,3]dioxine→benzyl (2-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)-2-hydroxyethyl)(6-(4-phenylbutoxy)hexyl)carbamate→1-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)-2-((6-(4-phenylbutoxy)hexyl)amino)ethanol→4-bromo-2-(hydroxymethyl)phenol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.